Business
HeartBeam Reports Fourth Quarter and Full Year 2025 Results
SANTA CLARA, Calif., March 12, 2026--HeartBeam Reports Fourth Quarter and Full Year 2025 Results
About this update from Heartbeam, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/feca447a9b517b3fd6a73ee16d8fa8e6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/V1Gu_WRu7fpujn_P65RzYg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/feca447a9b517b3fd6a73ee16d8fa8e6","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/uXFBubh0My30kGDrvkDdpA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/feca447a9b517b3fd6a73ee16d8fa8e6","width":1024,"height":512}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment","length":142,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"First Commercial Partner ClearCardio™ to Bring HeartBeam’s 3D ECG Technology to High-Growth Preventive Cardiology Market","length":120,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"First Patients Enrolled in Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion","length":112,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Completed the First Working Prototype of an Extended-Wear 12-Lead ECG Patch","length":75,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Strategic Collaboration with the Icahn School of Medicine at Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms","length":120,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Management to Host Webcast and Conference Call Today at 4:30 p.m. ET","length":68,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":637,"olType":false},{"type":"text","content":" ","length":6,"tagName":"p"},{"type":"text","content":"SANTA CLARA, Calif., March 12, 2026--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, has reported its financial and operational results for the fourth quarter and full year ended December 31, 2025.","length":304,"tagName":"p"},{"type":"text","content":"Fourth Q...